(Q36274692)

13 August 2017

Twelve month comparison of salmeterol and salbutamol as dry powder formulations in asthmatic patients. European Study Group (English)

1 reference

13 August 2017

0 references

0 references

Lundback B

1

1 reference

13 August 2017

Rawlinson DW

series ordinal

2

1 reference

13 August 2017

Palmer JB

series ordinal

3

1 reference

13 August 2017

language of work or name

English

0 references

publication date

1 February 1993

1 reference

13 August 2017

1 reference

13 August 2017

48

1 reference

13 August 2017

2

1 reference

13 August 2017

148-153

1 reference

Choice of drug treatment in asthma

13 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=464292

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=464292

Fenoterol: a beta2-adrenergic agonist for use in asthma. Pharmacology, pharmacokinetics, clinical efficacy and adverse effects

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=464292

Regular inhaled beta-agonist treatment in bronchial asthma.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=464292

Bronchodilator treatment in moderate asthma or chronic bronchitis: continuous or on demand? A randomised controlled study

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=464292

Salmeterol: a four week study of a long-acting beta-adrenoceptor agonist for the treatment of reversible airways disease

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=464292

Salmeterol, a novel, long-acting β2-adrenoceptor agonist: characterization of pharmacological activity in vitro and in vivo

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=464292

Duration of Protection by Inhaled Salmeterol in Exercise-induced Asthma

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=464292

Bronchodilating effect and side effects of beta2- adrenoceptor stimulants by different modes of administration (tablets, metered aerosol, and combinations thereof). A study with salbutamol in asthmatics

29 June 2018

1 reference

12 December 2020

Aerosolized bronchodilators and steroids in the treatment of airway obstruction in adults

1 reference

12 December 2020

Salmeterol, a new inhaled beta 2-adrenergic agonist, has a longer blocking effect than albuterol on hyperventilation-induced bronchoconstriction

1 reference

12 December 2020

A comparative study in atopic subjects with asthma of the effects of salmeterol and salbutamol on allergen-induced bronchoconstriction, increase in airway reactivity, and increase in urinary leukotriene E4 excretion

1 reference

12 December 2020

A Single-dose Comparison of Inhaled Albuterol and Two Formulations of Salmeterol on Airway Reactivity in Asthmatic Subjects

1 reference

12 December 2020

Identifiers

DOI

10.1136/THX.48.2.148

1 reference

13 August 2017

1 reference

13 August 2017

1 reference